A randomised double blind controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease.

被引:1
|
作者
Leiper, K
Woolner, JT
Parker, TJ
van der Vleit, M
Mullan, MM
Fear, S
Rhodes, JM
Hunter, JO
机构
[1] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
[2] Acad Hosp, Cambridge, England
[3] Roy Castle Int Ctr Lung Canc Res, Liverpool, Merseyside, England
关键词
D O I
10.1016/S0016-5085(00)84470-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
3032
引用
收藏
页码:A583 / A583
页数:1
相关论文
共 50 条
  • [31] Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease
    Akobeng, AK
    Miller, V
    Stanton, J
    Elbadri, AM
    Thomas, AG
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2000, 30 (01): : 78 - 84
  • [32] Efficacy of FPF 1070 (cerebrolysin) in patients with Alzheimer's disease. A multicentre, randomised, double-blind, placebo-controlled trial
    Shifu X.
    Heqin Y.
    Peifen Y.
    Luning W.
    Jianjun J.
    Xin M.
    Feng B.
    Jie L.
    Chunxie W.
    Zhihua D.
    Mingyi Z.
    Wenzhen X.
    Yinglu G.
    Cui M.
    Daping W.
    Binhua S.
    Clinical Drug Investigation, 2000, 19 (1) : 43 - 53
  • [33] Continued versus discontinued oxytocin stimulation in the active phase of labour (CONDISOX): double blind randomised controlled trial
    Boie, Sidsel
    Glavind, Julie
    Uldbjerg, Niels
    Steer, Philip J.
    Bor, Pinar
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 372
  • [34] Ethyl-EPA in Huntington's disease: A double blind, randomised, placebo controlled trial
    Murck, H
    Manku, M
    Puri, BK
    Leavitt, BR
    Hayden, MR
    Ross, CA
    Rosenblatt, A
    Greenamyre, JT
    Hersch, S
    Vaddadi, KS
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [35] Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
    Athauda, Dilan
    Maclagan, Kate
    Skene, Simon S.
    Bajwa-Joseph, Martha
    Letchford, Dawn
    Chowdhury, Kashfia
    Hibbert, Steve
    Budnik, Natalia
    Zampedri, Luca
    Dickson, John
    Li, Yazhou
    Aviles-Olmos, Iciar
    Warner, Thomas T.
    Limousin, Patricia
    Lees, Andrew J.
    Greig, Nigel H.
    Tebbs, Susan
    Foltynie, Thomas
    LANCET, 2017, 390 (10103): : 1664 - 1675
  • [37] Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial
    Sandborn, William J.
    Panes, Julian
    Danese, Silvio
    Sharafali, Zaineb
    Hassanali, Azra
    Jacob-Moffatt, Rhian
    Eden, Christopher
    Daperno, Marco
    Valentine, John F.
    Laharie, David
    Baia, Carolina
    Atreya, Raja
    Panaccione, Remo
    Rydzewska, Grazyna
    Aguilar, Humberto
    Vermeire, Severine
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (01): : 43 - 55
  • [38] Enteric-release glyceryl trinitrate in active Crohn's disease: a randomized, double-blind, placebo-controlled trial
    Hawkes, ND
    Richardson, C
    Ch'ng, CL
    Green, JT
    Evans, BK
    Williams, J
    Rhodes, P
    Rhodes, J
    Swift, GL
    Thomas, GAO
    Hawthorne, AB
    Kingham, JGC
    Mayberry, JF
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (12) : 1867 - 1873
  • [39] Methotrexate in chronic active Crohn's disease: A double-blind, randomized, Israeli multicenter trial
    Oren, R
    Moshkowitz, M
    Odes, S
    Becker, S
    Keter, D
    Pomeranz, I
    Shirin, C
    Reisfeld, I
    Broide, E
    Lavy, A
    Fich, A
    Eliakim, R
    Patz, J
    Villa, Y
    Arber, N
    Gilat, T
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1997, 92 (12): : 2203 - 2209
  • [40] Ornidazol for prophylaxis of postoperative Crohn's disease: Final results of a double blind placebo controlled trial
    Rutgeerts, P
    Van Assche, G
    D'Haens, G
    Baert, F
    Noman, M
    Aerden, I
    Geboes, K
    D'Hoore, A
    Penninckx, F
    GASTROENTEROLOGY, 2002, 122 (04) : A80 - A80